Kemnay Advisory Services Inc. Repligen Corp Transaction History

Kemnay Advisory Services Inc.

  • $546 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $662,550 - $814,761
-2,676 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $521,204 - $867,585
2,676 New
2,676 $773,000
Q4 2020

Feb 16, 2021
SELL
$148.08 - $206.57 $596,466 - $832,063
-4,028 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$122.51 - $158.27 $493,470 - $637,511
4,028 New
4,028 $594,000

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.94B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Kemnay Advisory Services Inc. Portfolio

Follow Kemnay Advisory Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kemnay Advisory Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kemnay Advisory Services Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email